CCA
AFRM icon

Cravens & Co Advisors’s Affirm AFRM Stock Holding History

Cravens & Co Advisors’s Portfolio AFRM Stock Details AFRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$551K Sell
6,751
-2,519
-27% -$165K 0.37% 49
2026
Q1 		$425K Buy
9,270
+575
+7% +$33.2K 0.28% 49
2025
Q4 		$661K Buy
8,695
+42
+0.5% +$3.02K 0.43% 40
2025
Q3 		$632K Sell
8,653
-2,690
-24% -$205K 0.43% 40
2025
Q2 		$784K Sell
11,343
-253
-2% -$13.1K 0.59% 36
2025
Q1 		$524K Sell
11,596
-537
-4% -$31.8K 0.41% 40
2024
Q4 		$739K Sell
12,133
-230
-2% -$12.8K 0.56% 37
2024
Q3 		$505K Sell
12,363
-1,349
-10% -$44.8K 0.39% 42
2024
Q2 		$414K Buy
13,712
+1,890
+16% +$60.6K 0.31% 50
2024
Q1 		$440K Sell
11,822
-95
-0.8% -$3.79K 0.37% 47
2023
Q4 		$586K Sell
11,917
-38
-0.3% -$1.1K 0.51% 43
2023
Q3 		$254K Buy
11,955
+109
+0.9% +$1.99K 0.24% 63
2023
Q2 		$182K Sell
11,846
-9,949
-46% -$132K 0.17% 68
2023
Q1 		$246K Buy
21,795
+2,457
+13% +$31K 0.23% 65
2022
Q4 		$187K Buy
+19,338
New +$291K 0.17% 78

Other funds holding AFRM

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Cravens & Co Advisors's AFRM Position: Q2 2026 in Review

Cravens & Co Advisors reduced its Affirm (AFRM) stake by 27% in Q2 2026, selling an estimated $165K and leaving 6,751 shares worth $551K. The position accounts for 0.37% of the portfolio, ranked #49.

Cravens & Co Advisors first reported a position in AFRM in Q4 2022 and has held it in 15 quarters since. The position peaked at $784K in Q2 2025. 660 funds tracked by Wall St. Rank hold AFRM as of Q2 2026.

  • Cravens & Co Advisors held 6,751 shares of Affirm worth $551K as of Q2 2026.
  • Cravens & Co Advisors sold 2,519 Affirm shares in Q2 2026, an estimated $165K.
  • Affirm made up 0.37% of Cravens & Co Advisors's portfolio in Q2 2026, its #49 holding.
  • Cravens & Co Advisors first reported a position in Affirm in Q4 2022 and has held it in 15 quarters since.
  • Cravens & Co Advisors's Affirm position peaked at $784K in Q2 2025.
  • 660 funds tracked by Wall St. Rank held Affirm as of Q2 2026.

Based on Cravens & Co Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.